60 DEGREES PHARMACEUTICALS, INC. - 8-K Filing

60 Degrees Pharmaceuticals reports clinical improvement and negative PCR results in all five completed expanded access Babesiosis study patients. (Items: 8.01 Other Events, 9.01 Financial Statements and Exhibits (a) Exhibits Number Description 99)

SEC EDGAR ·

Tickers: $SXTP

Read the full article at SEC EDGAR

More Regulatory news